# Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions

> **NCT02542007** · NA · COMPLETED · sponsor: **OrbusNeich** · enrollment: 440 (actual)

## Conditions studied

- Coronary Arteriosclerosis

## Interventions

- **DEVICE:** OrbusNeich Combo stent™
- **DEVICE:** sirolimus-eluting stent system

## Key facts

- **NCT ID:** NCT02542007
- **Lead sponsor:** OrbusNeich
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-05
- **Primary completion:** 2017-05-27
- **Final completion:** 2021-06-10
- **Target enrollment:** 440 (ACTUAL)
- **Last updated:** 2021-09-09

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02542007

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02542007, "Safety and Efficacy of the Combo Bio-engineered Sirolimus-eluting Stent Versus the Nano Polymer-free Sirolimus-eluting Stent in the Treatment of Patients With de Novo Stenotic Lesions". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02542007. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*